Lisa A. Marks's research while affiliated with Mayo Foundation for Medical Education and Research and other places

... Pollen, primarily produced by wind-pollinated plant species, is a major source of inhaled allergens. It is estimated that 10 to 30 percent of the global population suffers from seasonal allergic rhinitis and 300 million people suffer from asthma related to airborne pollen (Haahtela et al., 2013;Jyothirmayi and Kumar, 2019;Lopez-Santamarina et al., 2021;Brake et al., 2023). A high pollen load in the atmosphere has been linked to the prevalence of sensitization to aeroallergens in populations (Smith et al., 2014;Zwick et al., 1991;Beutner et al., 2021;Singh and Kumar, 2022). ...

... The Beijing Chaoyang Hospital's Ethics Committee's Institutional Review Board (No. 2020-3-16-18 and date of approval: 2020- [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] gave its approval to this work. All experiments involving human participants adhered to the institutional ethical guidelines and followed the principles of the Declaration of Helsinki. ...

... These approaches are driven by novel theories that integrate anatomical and inflammatory concepts (i.e., the mucosal concept), aimed at enhancing comprehension and management of the CRSwNP disease [18]. Although E-FESS has often been described as a complete sphenoethmoidal resection, associated with a maxillary antrostomy and a modification of the frontal sinus ostium [19][20][21], different surgical definitions, with no clear criteria by which to comprehensively define their appropriate extent, coexist in the literature, rendering an effective comparison of results among studies especially difficult [22,23]. ...

... While such cases are rare, they represent a persistent, likely growing minority (14)(15)(16), as there is little reason to expect that surgical procedures like colectomy or thyroidectomy occur in different rates between transgender and gender diverse (TGD) patients and non-TGD patients. Among such samples, incomplete information about sex and gender identity limits the ability to adjust for sex-specific confounders, especially with subsamples where recognized sex-specific confounders exist, such as chronic rhinosinusitis (17,18), bladder cancer (19), and colon cancer. (20) While it is notable that some gender diverse people may have received interventions intended to align sex characteristics with gender identity (i.e., hormone Incomplete information about sex and gender identity also limits the ability of surgical quality registries to achieve their intended purpose of improving outcomes and ensuring safety. ...

... Today, the advances in imaging and supermicrosurgical LVB confer an average decrease of 4.1 cm in limb volume and improve the quality-of-life measures in 57-100% of patients. [25][26][27][28][29][30] Despite scientific evidence that LVB can improve subjective and objective outcomes of lymphedema beyond CDT, the marked heterogeneity of practice limits the widespread adoption.6,19,20, [27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42] This narrative review aims to provide an overview of current LVB research, perioperative practices, and outcome measures to highlight essential gaps in the distributed investigation of LVB, which warrant further study and consensus. ...

... Topical intranasal corticosteroids (INCSs) are reported to be effective in improving nasal symptoms and reducing polyp scores and polyp recurrence postoperatively [88]. A meta-analysis indicated that moderate to high evidence of long-term use of INCS resulted in improvement in nasal obstruction via different delivery methods with minimal adverse effects [89]. ...

... 1,2 We highlight 4 papers in this issue that allow us to understand the current state of EHR use, identify unmet needs, provide evidence on their potential to uplift clinical practice and research, and their future potential to improve patient outcomes and address the perpetual problem of the "forgetful health system". [3][4][5][6] Although numerous studies have focused on assessing clinician experience with their EHR systems, few have in parallel obtained the patient's perspective. Meltzer et al, 3 in a survey of health practitioners and their patients from 2 primary care sites, finds discrepancies in experience and attitudes regarding EHR use between patient and clinician. ...

... Furthermore, evidence on the efficacy of ipilimumab and nivolumab, immune checkpoint inhibitors of PD-L1, is conflicting. Gritsch et al. reported a correlation between these agents and longer recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) in MBM patients [29]. In the same year, Guo et al. claimed that PD-1 inhibitors had questionable long-term neurological and cognitive sequelae; the drugs could potentially exacerbate radiation-related necrosis [30]. ...

... The current study assessed the receptivity to MCED testing among a diverse group of providers including staff physicians, residents and fellows, and APPs in primary care. Although there has been a call for incorporating MCED testing into routine cancer screening, there is currently only one clinical assay available-Grail Galleri [10]-and little is known about how this new testing will impact primary care [21]. We found that PCPs are generally receptive to the idea of incorporating MCED testing into their routine practice for cancer screening. ...

... Sclerotherapy, most commonly with the agent sodium tetradecyl sulfate (STS), can be effective as an alternative, although this technique can have serious risks and must be implemented with caution. 22 For all patients requiring operative procedures, we also offer the option of intranasal injection of 0.5 mL of bevacizumab 25 mg/mL in divided doses in the sphenopalatine foramen, posterior bony nasal septum, upper lateral nasal wall, and nasal floor bilaterally. 23 A recent prospective, double-blind RCT comparing this protocol with bipolar cauterization alone showed a clinically significant benefit 4 months after treatment. ...